Itron, Inc. (ITRI)

Elevation Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,723	4,896	3,435	2,288	3,102	3,874
Market Cap Growth	32.20%	42.52%	50.12%	-26.23%	-19.93%	16.63%
Enterprise Value	5,708	5,203	3,688	2,595	3,448	4,719
Last Close Price	123.79	108.58	75.51	50.65	68.52	95.90
PE Ratio	21.12	20.48	35.44	-	-	-
Forward PE	20.66	23.53	25.73	44.54	39.68	48.26
PS Ratio	2.29	2.01	1.58	1.27	1.57	1.78
PB Ratio	3.51	3.47	2.58	1.92	2.72	4.61
P/TBV Ratio	11.54	16.58	16.19	35.31	-	-
P/FCF Ratio	19.72	23.58	35.02	481.44	25.83	61.20
P/OCF Ratio	18.03	20.56	27.49	93.40	20.04	35.38
PEG Ratio	0.86	0.98	1.25	1.25	3.76	4.83
EV/Sales Ratio	2.34	2.13	1.70	1.45	1.74	2.17
EV/EBITDA Ratio	16.56	16.19	16.25	30.67	28.49	26.25
EV/EBIT Ratio	19.65	19.62	21.55	145.39	93.50	57.23
EV/FCF Ratio	19.89	25.06	37.60	546.03	28.71	74.55
Debt / Equity Ratio	0.78	0.91	0.38	0.43	0.46	1.20
Debt / EBITDA Ratio	3.41	3.69	2.01	4.76	3.63	4.92
Debt / FCF Ratio	4.43	6.18	5.12	107.90	4.36	15.89
Asset Turnover	0.71	0.81	0.87	0.75	0.79	0.82
Inventory Turnover	5.49	5.78	5.70	6.46	8.09	7.66
Quick Ratio	1.61	2.65	1.13	0.97	0.92	1.05
Current Ratio	2.04	3.44	1.95	1.66	1.50	1.69
Return on Equity (ROE)	18.76%	17.58%	7.79%	-0.82%	-7.90%	-6.93%
Return on Assets (ROA)	5.25%	5.51%	4.29%	0.47%	0.92%	1.94%
Return on Capital (ROIC)	6.68%	7.32%	6.05%	0.66%	1.31%	2.81%
Return on Capital Employed (ROCE)	11.00%	9.20%	8.30%	0.90%	1.90%	4.00%
Earnings Yield	4.77%	4.88%	2.82%	-0.43%	-2.62%	-1.50%
FCF Yield	5.07%	4.24%	2.85%	0.21%	3.87%	1.63%
Buyback Yield / Dilution	0.25%	-0.77%	-1.63%	-1.81%	-10.06%	-0.68%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q